Compare, Analyse Aurobindo Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

AUROBINDO PHARMA     Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AUROBINDO PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
AUROBINDO PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs830380-   
Low Rs527274-   
Sales per share (Unadj.) Rs333.9113.0-  
Earnings per share (Unadj.) Rs40.4-28.5-  
Cash flow per share (Unadj.) Rs51.8-23.6-  
Dividends per share (Unadj.) Rs2.500-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs237.188.7-  
Shares outstanding (eoy) m585.91168.78-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.02.9 70.2%   
Avg P/E ratio x16.8-11.5 -146.4%  
P/CF ratio (eoy) x13.1-13.9 -94.6%  
Price / Book Value ratio x2.93.7 77.6%  
Dividend payout %6.20-   
Avg Mkt Cap Rs m397,56955,187 720.4%   
No. of employees `00017.94.3 415.9%   
Total wages/salary Rs m25,8493,464 746.3%   
Avg. sales/employee Rs Th10,956.94,443.0 246.6%   
Avg. wages/employee Rs Th1,447.7806.8 179.4%   
Avg. net profit/employee Rs Th1,324.3-1,119.5 -118.3%   
INCOME DATA
Net Sales Rs m195,63619,074 1,025.7%  
Other income Rs m1,553134 1,162.9%   
Total revenues Rs m197,18919,207 1,026.6%   
Gross profit Rs m39,519-3,305 -1,195.6%  
Depreciation Rs m6,680823 811.4%   
Interest Rs m2,626517 508.3%   
Profit before tax Rs m31,767-4,512 -704.1%   
Minority Interest Rs m27-13 -214.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-8810-   
Tax Rs m7,269282 2,578.3%   
Profit after tax Rs m23,645-4,806 -492.0%  
Gross profit margin %20.2-17.3 -116.6%  
Effective tax rate %22.9-6.2 -366.2%   
Net profit margin %12.1-25.2 -48.0%  
BALANCE SHEET DATA
Current assets Rs m153,64513,970 1,099.8%   
Current liabilities Rs m120,4297,860 1,532.2%   
Net working cap to sales %17.032.0 53.0%  
Current ratio x1.31.8 71.8%  
Inventory Days Days135111 121.9%  
Debtors Days Days64124 51.4%  
Net fixed assets Rs m103,9098,143 1,276.1%   
Share capital Rs m58689 661.6%   
"Free" reserves Rs m138,3220-   
Net worth Rs m138,90814,971 927.9%   
Long term debt Rs m1,8005,261 34.2%   
Total assets Rs m264,54428,281 935.4%  
Interest coverage x13.1-7.7 -169.4%   
Debt to equity ratio x00.4 3.7%  
Sales to assets ratio x0.70.7 109.7%   
Return on assets %9.9-15.2 -65.5%  
Return on equity %17.0-32.1 -53.0%  
Return on capital %23.8-19.8 -120.3%  
Exports to sales %49.60-   
Imports to sales %18.80-   
Net fx Rs m56,7270-   
CASH FLOW
From Operations Rs m16,2201,628 996.3%  
From Investments Rs m-28,768-500 5,754.9%  
From Financial Activity Rs m19,1914,775 401.9%  
Net Cashflow Rs m6,6565,903 112.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.24 Rs / ZAR

Compare AUROBINDO PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare AUROBINDO PHARMA With: SHASUN PHARMA  NEULAND LABS  GSK PHARMA  PANACEA BIOTECH  TTK HEALTHCARE  



Today's Market

Sensex, Nifty Snap 4-Day Winning Streak; JSW Steel and Hindalco Among Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views On News

SUN PHARMA at 52 Week High; BSE 500 Index Down 0.5% (Market Updates)

May 11, 2021 | Updated on May 11, 2021

SUN PHARMA share price has hit a 52-week high. It is presently trading at Rs 721. BSE 500 Index is down by 0.5% at 20,096. Within the BSE 500, SUN PHARMA (up 3.2%) and CHENNAI PETROLEUM (up 7.1%) are among the top gainers, while top losers are INTELLECT DESIGN and SAIL.

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

AUROBINDO PHARMA SHARE PRICE


May 11, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 5-YR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS